Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-25-001613
Filing Date
2025-08-07
Accepted
2025-08-07 16:58:47
Documents
73
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q qnrx-20250630x10q.htm   iXBRL 10-Q 974599
2 EX-31.1 qnrx-20250630xex31d1.htm EX-31.1 11901
3 EX-31.2 qnrx-20250630xex31d2.htm EX-31.2 11883
4 EX-32.1 qnrx-20250630xex32d1.htm EX-32.1 5719
5 EX-32.2 qnrx-20250630xex32d2.htm EX-32.2 6484
  Complete submission text file 0001410578-25-001613.txt   4855554

Data Files

Seq Description Document Type Size
6 EX-101.SCH qnrx-20250630.xsd EX-101.SCH 45556
7 EX-101.CAL qnrx-20250630_cal.xml EX-101.CAL 31645
8 EX-101.DEF qnrx-20250630_def.xml EX-101.DEF 170094
9 EX-101.LAB qnrx-20250630_lab.xml EX-101.LAB 356700
10 EX-101.PRE qnrx-20250630_pre.xml EX-101.PRE 273660
76 EXTRACTED XBRL INSTANCE DOCUMENT qnrx-20250630x10q_htm.xml XML 677513
Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Filer) CIK: 0001671502 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 10-Q | Act: 34 | File No.: 001-37846 | Film No.: 251195123
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)